文献速递头颈部肿瘤放疗放疗物理与技术

鼻咽癌放疗中基于自动分割分次FBCT的实时形态与剂量适应

Real-time morphological and dosimetric adaptation in nasopharyngeal carcinoma radiotherapy: insights from autosegmented fractional fan-beam CT.
PubMed 文献 · Radiat Oncol · 2025-04-30

该回顾性研究分析23例鼻咽癌患者681次FBCT扫描,用四种深度学习自动分割模型评估每周体积、DSC和剂量变化。结果显示腮腺、颌下腺、甲状腺、脊髓和靶区体积及DSC呈线性下降,剂量偏差随时间进展,第3-6周变化最显著,提示需自适应放疗干预但无需频繁进行。

要点

  • 腮腺、颌下腺、甲状腺、脊髓和靶区体积及DSC呈线性下降(R²>0.7)。
  • 低危PTV覆盖线性下降3.01%,腮腺平均剂量增加2.45 Gy,甲状腺增加1.18 Gy。
  • PGTVns靶区覆盖最大降幅达7.15%,OAR剂量变化多不超过3 Gy。

核心结论

  • 鼻咽癌放疗中进展性剂量偏差可能无法仅通过重新摆位纠正,需要自适应放疗干预。
  • OAR剂量变化很少超过3 Gy且靶区覆盖波动在10%以内,自适应放疗无需频繁进行,第3-6周为最适窗口。

研究设计与样本

  • 回顾性研究分析2022年8月至2024年5月在中山大学肿瘤防治中心治疗的23例鼻咽癌患者共681次FBCT扫描。
  • 纳入标准为通过CT-linac每周至少1次FBCT且扫描间不超过2次分次。
  • 开发四种基于深度学习的自动分割模型评估OAR和靶区的每周体积、DSC和剂量变化。

主要发现

  • FBCT自动分割系统评价显示总体精度满意,分割错误经手动修改。
  • 腮腺、颌下腺、甲状腺、脊髓和靶区体积和/或DSC呈线性下降(R²>0.7)。
  • 线性剂量变化包括低危PTV覆盖-3.01%、腮腺平均剂量+2.45 Gy、甲状腺+1.18 Gy、脑干D1%+0.56 Gy、脊髓最大剂量+1.12 Gy。
  • PGTVns靶区覆盖降幅最大达7.15%,最显著剂量变化发生在第3-6周。

临床怎么用

  • 鼻咽癌放疗期间进展性剂量偏差可能无法仅通过重新摆位纠正,需考虑自适应放疗干预。
  • 因OAR剂量变化很少超过3 Gy且靶区覆盖波动在10%以内,自适应放疗无需频繁进行,第3-6周为最适窗口。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To quantify morphological and dosimetric variations in nasopharyngeal carcinoma (NPC) radiotherapy via autosegmented fan-beam computed tomography (FBCT) and to inform decision-making regarding appropriate objectives and optimal timing for adaptive radiotherapy (ART). METHODS: This retrospective study analyzed 23 NPC patients (681 FBCT scans) treated at Sun Yat-sen Cancer Center from August 2022 to May 2024. The inclusion criterion was as follows: ≥1 weekly FBCT via a CT-linac with ≤ 2 fractions between scans. Four deep learning-based autosegmentation models were developed to assess weekly volume, Dice similarity coefficient (DSC), and dose variations in organs at risk (OARs) and target volumes. RESULTS: A systematic review of autosegmentation on FBCT scans demonstrated satisfactory accuracy overall, and missegmentation was manually modified. Linear decreases in volume and/or DSC were observed in the parotid glands, submandibular glands, thyroid, spinal cord, and target volumes (R² > 0.7). The linear dose variation included coverage of the low risk planning target volume (-3.01%), the mean dose to the parotid glands (+ 2.45 Gy) and thyroid (+ 1.18 Gy), the D1% of the brainstem (+ 0.56 Gy), and the maximum dose to the spinal cord (+ 1.12 Gy). The greatest reduction in target volume coverage was noted in PGTVns, reaching 7.15%. The most significant dose changes occurred during weeks 3-6. CONCLUSIONS: During NPC radiotherapy, the progressive dose deviations may not be corrected through repositioning alone, necessitating ART intervention. As dose variations in OARs rarely exceed 3 Gy and target coverage fluctuations remain within 10%, ART does not need to be performed frequently, and weeks 3-6 represent the most appropriate window.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Yu XL, Hu J, Yang YX, et al. Real-time morphological and dosimetric adaptation in nasopharyngeal carcinoma radiotherapy: insights from autosegmented fractional fan-beam CT. Radiat Oncol. 2025. PMID: 40307931. doi:10.1186/s13014-025-02643-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。